Anti-vascular endothelial growth factor for proliferative diabetic retinopathy-Reference-Cited by-同舟云学术

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

Published:2023-03-20 Issue:3 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Martinez-Zapata Maria José¹,Salvador Ignacio²,Martí-Carvajal Arturo J³⁴⁵,Pijoan José I⁶⁷,Cordero José A⁸,Ponomarev Dmitry⁹,Kernohan Ashleigh¹⁰,Solà Ivan¹,Virgili Gianni¹¹¹²

Affiliation:

1. Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau); CIBER Epidemiología y Salud Pública (CIBERESP); Barcelona Spain

2. Hospital de Sant Pau; Barcelona Spain

3. Facultad de Ciencias de la Salud Eugenio Espejo; Universidad UTE (Cochrane Ecuador); Quito Ecuador

4. Universidad Francisco de Vitoria; Facultad de Medicina Cochrane Madrid; Madrid Spain

5. Cátedra Rectoral de Medicina Basada en la Evidencia; Universidad de Carabobo; Valencia Venezuela

6. Hospital Universitario Cruces; Barakaldo Spain

7. BioCruces-Bizkaia Research Institute; CIBER Epidemiología y Salud Pública (CIBERESP); Barakaldo Spain

8. Blanquerna School of Health Sciences; Universitat Ramon Llull; Barcelona Spain

9. Interdepartmental Division of Critical Care Medicine; University of Toronto; Toronto Canada

10. Population Health Sciences Institute; Newcastle University; Newcastle upon Tyne UK

11. Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA); University of Florence; Florence Italy

12. Centre for Public Health; Queen's University Belfast; Belfast UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference251 articles.

1. Comparison between panretinal photocoagulation and panretinal photocoagulation plus intravitreal bevacizumab in proliferative diabetic retinopathy;Ahmad;Journal of Ayub Medical College,2012

2. Ali W Abbasi KZ Raza A Panretinal photocoagulation plus intravitreal bevacizumab versus panretinal photocoagulation alone for proliferative diabetic retinopathy Journal of the College of Physicians and Surgeons Pakistan 2018 28 12 923-7

3. Efficacy of Intravitreal ranibizumab Injections in the treatment of vitreous hemorrhage related to proliferative diabetic retinopathy;Chelala;Retina,2018

4. Dirani A Fadlallah A Azar G Chelala E Nehme J Alameddine R Intravitreal ranibizumab for vitreous hemorrhage in proliferative diabetic retinopathy Investigative Ophthalmology and Visual Science 2014 55 13 ARVO E abstract 4395

5. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy;Bhavsar;JAMA Ophthalmology,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How does anti-vascular endothelial growth factor (anti-VEGF) with or without panretinal photocoagulation (PRP) compare with PRP alone for adults with proliferative diabetic retinopathy?;Cochrane Clinical Answers;2023-11-24

2. TNFSF15 Inhibits Progression of Diabetic Retinopathy by Blocking Pyroptosis via Interacting with GSDME;2023-10-17